Monday, April 10, 2023 5:43:54 PM
SL,
Presentations in the ASCO conference where an Abstract has been submitted, reviewed and deemed worthy of a presentation are considered a peer reviewed. Once something is peer reviewed the company is free to discuss it. The depth of the review or data presented may not be a great as with a Journal, but companies routinely discuss and present data after it's been presented in a technical conference.
An appearance in the Experts Theater is not considered peer reviewed at all, but the company is free to present data that's previously been peer reviewed there. ASCO won't accept a presentation of information where everything to be presented has already been peer reviewed by others, if something new is added a presentation could be accepted.
The company has a history of presenting at the Experts Theater, I believe corporate personnel make such presentations, though I suppose the clinicians may support them. In the past I believe that the company also had patients who received the vaccine discuss it or at least appear at the Experts Theater. Certainly Drs. attending ASCO may attend the Experts Theater, but it's largely intended to communicate with the investors population.
Gary
Presentations in the ASCO conference where an Abstract has been submitted, reviewed and deemed worthy of a presentation are considered a peer reviewed. Once something is peer reviewed the company is free to discuss it. The depth of the review or data presented may not be a great as with a Journal, but companies routinely discuss and present data after it's been presented in a technical conference.
An appearance in the Experts Theater is not considered peer reviewed at all, but the company is free to present data that's previously been peer reviewed there. ASCO won't accept a presentation of information where everything to be presented has already been peer reviewed by others, if something new is added a presentation could be accepted.
The company has a history of presenting at the Experts Theater, I believe corporate personnel make such presentations, though I suppose the clinicians may support them. In the past I believe that the company also had patients who received the vaccine discuss it or at least appear at the Experts Theater. Certainly Drs. attending ASCO may attend the Experts Theater, but it's largely intended to communicate with the investors population.
Gary
Bullish
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
